Zobrazeno 1 - 10
of 48
pro vyhledávání: '"J. A. Liu Yin"'
Autor:
J A Liu Yin, P. Wood
Publikováno v:
Clinical & Laboratory Haematology. 16:201-204
Publikováno v:
Bone Marrow Transplantation. 36:67-70
Relapse postautograft in acute myeloid leukaemia (AML), may in part arise from leukaemia cells present in the bone marrow (BM) inoculum, and the level of minimal residual disease (MRD) in BM harvests used for autografting may therefore be clinically
Autor:
Miguel A. Sanz, C Martínez, Arnold Ganser, Aruna Raghavachar, Dieter Hoelzer, L. B. To, Lothar Kanz, Eric Archimbaud, Jeff Szer, Kerry Taylor, J. A. Liu Yin, Klaus Geissler
Publikováno v:
Annals of Hematology. 82:677-683
Pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) administered after acute myeloid leukemia (AML) chemotherapy (CT) failed to shorten the time of transfusion-dependent thrombocytopenia in a previous study. In this
Autor:
Katy Rezvani, Rachel Pawson, H. G. Prentice, Saad M. B. Rassam, J. A. Liu Yin, Charles Craddock, M. N. Potter, Mamta Garg, P. Theocharous, Mark Lawler
Publikováno v:
British Journal of Haematology. 115:622-629
Acute leukaemias in relapse after allogeneic stem cell transplantation (SCT) respond poorly to donor leucocyte infusions (DLI) compared with chronic myeloid leukaemia (CML), at least in part because of faster disease kinetics. Fludarabine-containing
Publikováno v:
British Journal of Haematology. 108:743-746
Pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) can stimulate megakaryopoiesis in vitro in some myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML) patients. We assessed PEG-rHuMGDF combined with gra
Autor:
M Macheta, Godfrey R Morgenstern, James Chang, P A Evans, J. A. Liu Yin, Khalid Tobal, Gareth J Morgan, Guy S. Lucas, J Newton
Publikováno v:
Blood. 95:815-819
One of the most common translocations in acute myeloid leukemia (AML) is the t(8;21), which produces the fusion gene AML1-MTG8. We have developed a sensitive competitive reverse transcriptase-polymerase chain reaction (RT-PCR) assay forAML1-MTG8 tran
Autor:
K Tobal, J A Liu Yin
Publikováno v:
Leukemia. 12:1349-1354
RT-PCR methods have been developed, to date, by various groups to amplify the PML-RARA fusion gene produced by the t(15;17) in APL patients. However, these methods lack the necessary sensitivity to detect minimal residual disease (MRD) below the leve
Publikováno v:
British Journal of Haematology. 99:921-924
Patients in long-term remission of acute myeloid leukaemia (AML) M2 with t(8;21) after chemotherapy, with or without bone marrow transplantation, are known to retain residual cells which express AML1/MTG8 transcripts in bone marrow, detectable by RT-
Publikováno v:
British Journal of Haematology. 99:139-146
Mpl ligand is a recently cloned haemopoietic growth factor that stimulates megakaryopoiesis in vitro and in vivo. We describe the in vitro effect of a truncated form of Mpl ligand, recombinant human megakaryocyte growth and development factor (rHuMGD
Publikováno v:
British Journal of Haematology. 91:104-108
The pericentric inversion of chromosome 16 [inv(16)(p13q22)] and t(16;16)(p13;q22) are chromosomal rearrangements frequently associated with AML FAB type M4Eo resulting in the production of a fusion gene CBFB/MYH11. We studied 17 patients with a chro